Retatrutide 20mg — Triple Agonist Research Peptide
Retatrutide 20mg is a research-grade triple receptor agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously, formulated for advanced obesity and metabolic pathway research. Each vial contains 20mg of Retatrutide at 99% purity, HPLC-verified by Beyond Health Lab.
What Is Retatrutide 20mg?
Retatrutide is a next-generation triple incretin receptor agonist that activates GIP, GLP-1, and glucagon receptors, making it one of the most potent metabolic research compounds available. Retatrutide 15mg is studied for its ability to combine the metabolic benefits of all three receptor pathways, including enhanced energy expenditure through glucagon activation.
Research Applications
Retatrutide 20mg is actively studied in the following areas:
- Triple GIP, GLP-1, and glucagon receptor agonism research
- Enhanced energy expenditure pathway studies
- Advanced obesity and weight reduction research
- Insulin sensitivity and glycemic control studies
- Comparative triple vs dual incretin receptor research
- Hepatic lipid metabolism and NASH research
Why Choose Beyond Health Lab Retatrutide 20mg?
Every batch of Retatrutide 20mg at Beyond Health Lab is rigorously HPLC-tested to guarantee ≥99% purity before dispatch. Our lyophilized formulation ensures the peptide remains stable during transit and storage, giving your laboratory consistent, reliable results.
Product Specifications
- Compound: Retatrutide (Triple GIP/GLP-1/Glucagon Receptor Agonist)
- Amount: 20mg per vial
- Purity: ≥99% (HPLC-verified)
- Form: Lyophilized powder
- Storage: Keep refrigerated at 2–8°C
- Shipping: 2–5 business days
- Use: Research and laboratory use only
Frequently Asked Questions
What is Retatrutide 20mg used for in research?
Retatrutide 20mg is studied for triple GIP, GLP-1, and glucagon receptor agonism research. Its unique three-receptor mechanism is investigated for superior metabolic effects compared to single and dual incretin agonists.
How does Retatrutide differ from Tirzepatide?
Tirzepatide activates GIP and GLP-1 receptors (dual agonist), while Retatrutide also activates the glucagon receptor (triple agonist). The glucagon activation adds enhanced energy expenditure effects studied in obesity research.
Can Retatrutide 20mg be compared with Semaglutide and Tirzepatide?
Yes. Researchers frequently conduct comparative studies between Semaglutide, Tirzepatide, and Retatrutide to evaluate the dose-response differences across single, dual, and triple incretin receptor agonism.
How should Retatrutide 20mg be stored?
Unreconstituted vials should be stored refrigerated at 2–8°C away from direct light. Once reconstituted with bacteriostatic water, keep refrigerated and handle under sterile laboratory conditions.
What purity standard does Beyond Health Lab use for Retatrutide 20mg?
Every vial of Retatrutide 20mg is HPLC-tested to guarantee ≥99% purity. Full Certificates of Analysis are available upon request for every batch before release.
All products sold by Beyond Health Lab are intended strictly for in vitro research and laboratory use only.
Reviews
There are no reviews yet.